Barclays’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-100,547
Closed -$614K 4958
2021
Q3
$614K Buy
100,547
+17,718
+21% +$110K ﹤0.01% 3075
2021
Q2
$682K Sell
82,829
-20,422
-20% -$174K ﹤0.01% 2895
2021
Q1
$924K Sell
103,251
-13,192
-11% -$151K ﹤0.01% 2828
2020
Q4
$1.34M Sell
116,443
-1,867
-2% -$21.7K ﹤0.01% 2556
2020
Q3
$1.23M Buy
118,310
+84,762
+253% +$1.04M ﹤0.01% 2508
2020
Q2
$441K Buy
33,548
+7,332
+28% +$76K ﹤0.01% 3438
2020
Q1
$205K Sell
26,216
-149,706
-85% -$2.25M ﹤0.01% 4276
2019
Q4
$3.64M Buy
175,922
+48,456
+38% +$817K ﹤0.01% 2351
2019
Q3
$1.75M Buy
127,466
+77,766
+156% +$923K ﹤0.01% 3036
2019
Q2
$612K Buy
49,700
+3,601
+8% +$41.5K ﹤0.01% 4148
2019
Q1
$574K Buy
46,099
+36,262
+369% +$485K ﹤0.01% 3985
2018
Q4
$111K Sell
9,837
-3,412
-26% -$53.5K ﹤0.01% 4975
2018
Q3
$248K Buy
13,249
+10,789
+439% +$248K ﹤0.01% 4841
2018
Q2
$64K Sell
2,460
-6,863
-74% -$178K ﹤0.01% 5514
2018
Q1
$210K Buy
9,323
+4,124
+79% +$101K ﹤0.01% 4798
2017
Q4
$130K Buy
5,199
+3,773
+265% +$92.4K ﹤0.01% 5034
2017
Q3
$34K Buy
1,426
+1,015
+247% +$23.9K ﹤0.01% 5557
2017
Q2
$8K Sell
411
-4,340
-91% -$90.4K ﹤0.01% 6130
2017
Q1
$127K Sell
4,751
-55,620
-92% -$1.14M ﹤0.01% 4707
2016
Q4
$1.15M Buy
60,371
+45,412
+304% +$868K ﹤0.01% 2613
2016
Q3
$292K Buy
14,959
+14,633
+4,489% +$248K ﹤0.01% 3649
2016
Q2
$5K Buy
326
+200
+159% +$2.51K ﹤0.01% 5758
2016
Q1
$1K Sell
126
-102
-45% -$1.24K ﹤0.01% 6045
2015
Q4
$4K Buy
228
+155
+212% +$2.69K ﹤0.01% 5638
2015
Q3
$1K Sell
73
-193
-73% -$4.53K ﹤0.01% 6660
2015
Q2
$5K Buy
266
+83
+45% +$1.67K ﹤0.01% 6489
2015
Q1
$4K Sell
183
-306
-63% -$7.09K ﹤0.01% 6721
2014
Q4
$10K Buy
489
+341
+230% +$6.18K ﹤0.01% 6733
2014
Q3
$3K Sell
148
-674
-82% -$9.76K ﹤0.01% 7351
2014
Q2
$11K Sell
822
-1,101
-57% -$15K ﹤0.01% 6799
2014
Q1
$31K Buy
+1,923
New +$33.2K ﹤0.01% 6352